HARBIN, China, May 28 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced that Mr. Hubert Cooleman, Flemish economic representative for the North of the PRC and Mongolia, visited Harbin Tian Di Ren Medical Company ("TDR"), a wholly-owned subsidiary of China Sky One, in Harbin on May 26, 2009.
China Sky One management presented and discussed the Company's recent developments with Mr. Cooleman, including its strong product portfolio, its expanded international sales network, and its ongoing research and development projects. In his capacity as economic representative for the North of the PRC, Mr. Cooleman provided suggestions for expanding into Belgium, one of the most advanced countries in the field of biomedical engineering, in order to strengthen ties with the Chinese market.
At the end of the Company's meeting with Mr. Cooleman, a tentative business proposal was reached, which served as a memorandum for the efforts of all parties involved in the discussions. This covered a number of areas, including market entry into both Belgium and China as well as research and development cooperation between both countries. Ms. Xiao-yan Han, Vice Chairman and COO of China Sky One, and Mr. Stanley Hao, CFO of China Sky One, as well as Directors in the international business and research and development departments of the Company, joined the meeting.
"We appreciate Mr. Cooleman's visit to China Sky One and his efforts to help build strong working relationships and a bridge between companies in our two countries," said Ms. Xiao-yan Han, Vice Chairman and COO of China Sky One Medical. "We will continue this dialogue and explore more opportunities in Europe, including international trade and science and technology cooperation opportunities.
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio- Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.skyonemedical.com.
Safe Harbor Statement
Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding international cooperation. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.
Company Contact: Investor Relations Contact: China Sky One Medical, Inc. CCG Investor Relations Mr. Stanley Hao, CFO Mr. Crocker Coulson, President Tel: +86-0451-53994069 Tel: +1-646-213-1915 Email: email@example.com Email: firstname.lastname@example.org Website: www.ccgirasia.com
|SOURCE China Sky One Medical, Inc.|
Copyright©2009 PR Newswire.
All rights reserved